Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 210

1.

Oral delivery of poorly soluble compounds by supersaturated systems.

Lee TW, Boersen NA, Hui HW, Kurtulik P.

Ther Deliv. 2011 Jun;2(6):685-90.

PMID:
22822502
2.

Potential of ordered mesoporous silica for oral delivery of poorly soluble drugs.

Vialpando M, Martens JA, Van den Mooter G.

Ther Deliv. 2011 Aug;2(8):1079-91. Review.

PMID:
22833866
3.

Exploring oral nanoemulsions for bioavailability enhancement of poorly water-soluble drugs.

Kotta S, Khan AW, Pramod K, Ansari SH, Sharma RK, Ali J.

Expert Opin Drug Deliv. 2012 May;9(5):585-98. doi: 10.1517/17425247.2012.668523. Epub 2012 Mar 9. Review. Erratum in: Expert Opin Drug Deliv. 2012 Nov;9(11):1441.

PMID:
22512597
4.

Targeting of injectable drug nanocrystals.

Fuhrmann K, Gauthier MA, Leroux JC.

Mol Pharm. 2014 Jun 2;11(6):1762-71. doi: 10.1021/mp5001247. Epub 2014 Apr 25. Review.

PMID:
24766270
5.

Lipid-based systems for the enhanced delivery of poorly water soluble drugs.

Porter CJ, Wasan KM, Constantinides P.

Adv Drug Deliv Rev. 2008 Mar 17;60(6):615-6. Epub 2007 Nov 4. No abstract available.

PMID:
18160174
6.

Nanocarriers for oral drug delivery.

Zhang L, Wang S, Zhang M, Sun J.

J Drug Target. 2013 Jul;21(6):515-27. doi: 10.3109/1061186X.2013.789033. Epub 2013 Apr 26. Review.

PMID:
23621127
7.

New perspectives on lipid and surfactant based drug delivery systems for oral delivery of poorly soluble drugs.

Müllertz A, Ogbonna A, Ren S, Rades T.

J Pharm Pharmacol. 2010 Nov;62(11):1622-36. doi: 10.1111/j.2042-7158.2010.01107.x. Review.

PMID:
21039546
8.
9.

Controlling drug nanoparticle formation by rapid precipitation.

D'Addio SM, Prud'homme RK.

Adv Drug Deliv Rev. 2011 May 30;63(6):417-26. doi: 10.1016/j.addr.2011.04.005. Epub 2011 Apr 30. Review.

PMID:
21565233
10.

Nanoparticles for drug delivery: review of the formulation and process difficulties illustrated by the emulsion-diffusion process.

Moinard-Checot D, Chevalier Y, Briançon S, Fessi H, Guinebretière S.

J Nanosci Nanotechnol. 2006 Sep-Oct;6(9-10):2664-81. Review.

PMID:
17048474
11.

Recent advances in intravenous delivery of poorly water-soluble compounds.

Shi Y, Porter W, Merdan T, Li LC.

Expert Opin Drug Deliv. 2009 Dec;6(12):1261-82. doi: 10.1517/17425240903307423. Review.

PMID:
19941409
12.

High drug loading self-microemulsifying/micelle formulation: design by high-throughput formulation screening system and in vivo evaluation.

Sakai K, Obata K, Yoshikawa M, Takano R, Shibata M, Maeda H, Mizutani A, Terada K.

Drug Dev Ind Pharm. 2012 Oct;38(10):1254-61. doi: 10.3109/03639045.2011.645832. Epub 2012 Feb 17.

PMID:
22339057
13.

Oral fast-release solid dispersion-paradigm shift to nanoparticles.

Wong TW.

Recent Pat Drug Deliv Formul. 2011 Sep;5(3):227-43. Review.

PMID:
21834774
14.

Lipid-based nanocarriers as an alternative for oral delivery of poorly water- soluble drugs: peroral and mucosal routes.

Silva AC, Santos D, Ferreira D, Lopes CM.

Curr Med Chem. 2012;19(26):4495-510. Review.

PMID:
22834821
15.

Self-emulsifying drug delivery systems: an approach to enhance oral bioavailability.

Kohli K, Chopra S, Dhar D, Arora S, Khar RK.

Drug Discov Today. 2010 Nov;15(21-22):958-65. doi: 10.1016/j.drudis.2010.08.007. Epub 2010 Aug 17. Review.

PMID:
20727418
16.

Drug delivery strategies for poorly water-soluble drugs.

Fahr A, Liu X.

Expert Opin Drug Deliv. 2007 Jul;4(4):403-16. Review.

PMID:
17683253
17.

Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.

Dahan A, Hoffman A.

J Control Release. 2008 Jul 2;129(1):1-10. doi: 10.1016/j.jconrel.2008.03.021. Epub 2008 Apr 1. Review.

PMID:
18499294
18.

In vivo evaluation of tablets and capsules containing spray-dried o/w-emulsions for oral delivery of poorly soluble drugs.

Hansen T, Holm P, Rohde M, Schultz K.

Int J Pharm. 2005 Apr 11;293(1-2):203-11.

PMID:
15778058
19.

Lipid nanoparticles for the delivery of poorly water-soluble drugs.

Bunjes H.

J Pharm Pharmacol. 2010 Nov;62(11):1637-45. doi: 10.1111/j.2042-7158.2010.01024.x. Review.

PMID:
21039547
20.

Enhancing intestinal drug solubilisation using lipid-based delivery systems.

Porter CJ, Pouton CW, Cuine JF, Charman WN.

Adv Drug Deliv Rev. 2008 Mar 17;60(6):673-91. Epub 2007 Nov 7. Review.

PMID:
18155801

Supplemental Content

Support Center